Saphena Medical has raised $3m in its series A round from a consortium including medical-equipment maker STD Med.

Pavilion Medical Innovations, which incubates and commercializes medical technologies, also invested in Saphena Medical, a device company developing technology to harvest veins for use in coronay artery bypass grafting.

Michael Glennon, founder of Pavilion and who will serve as president of Saphena Medical, said: “This funding and our close working relationship with the experts at STD Med will enable Saphena Medical to…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?